Naglazyme and pneumonia Patient Reports February 11, 2012

Naglazyme Side Effects Report #6065703-4
Naglazyme side effect was reported by a Physician from TURKEY on Jan 16, 2009. Male patient, child 8 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, pneumonia , upper respiratory tract infection. Naglazyme dosage: 20 MG; QW; IVDRP. Patient was hospitalized. Patient died on 11/14/2008.

Naglazyme Side Effects Report #5397300-8
Naglazyme side effect was reported by a Health Professional from COLOMBIA on July 06, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, cardiac failure congestive, culture positive, pneumonia , pulmonary hypertension , staphylococcal infection . Naglazyme dosage: 10 MG, QW; IV. During the same period patient was treated with BETA, BRONCHLODIALTOR, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5413007-2
Naglazyme side effect was reported by a Health Professional from COLOMBIA on July 25, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, cardiac failure congestive, culture positive, oxygen saturation decreased, pneumonia , pulmonary hypertension , respiratory distress, sleep study abnormal. Naglazyme dosage: 10 MG; QW; IV. During the same period patient was treated with BETA, BRONCHODILATOR, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5443298-3
Naglazyme side effect was reported by a Health Professional from COLOMBIA on Aug 15, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: acute respiratory failure, alpha haemolytic streptococcal infection, cardiac failure congestive, haemodynamic instability, no therapeutic response, pneumonia , pulmonary hypertension , sleep apnoea syndrome, staphylococcal infection . Naglazyme dosage: 10 MG; QW; IV. During the same period patient was treated with BRONCHODILATOR, OXYGEN, FUROSEMIDE, BETA. Patient was hospitalized. Patient recovered.


Naglazyme Side Effects Report #5893094-8
Naglazyme side effect was reported by a Consumer or non-health professional from AUSTRALIA on Sept 04, 2008. Female patient, 28 years of age, weighting 68.34 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia , sepsis . Naglazyme dosage: 22 MG; QW; IVDRP. Patient was hospitalized. Patient died on 09/02/2008.

Naglazyme Side Effects Report #5946393-5
Naglazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2008. Female patient, 28 years of age, weighting 68.34 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure congestive, chest pain , dyspnoea, international normalised ratio abnormal, pneumonia , sepsis . Naglazyme dosage: 22 MG;QW;IVDRP. Patient was hospitalized. Patient died on 08/30/2008.

Naglazyme Side Effects Report #5935180-X
Naglazyme side effect was reported by a Physician from BRAZIL on Oct 13, 2008. Male patient, 18 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cardiac failure, pneumonia . Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6137499-9
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 12, 2009. Female patient, 15 years of age, weighting 37.48 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypotension, infusion related reaction, pneumonia . Naglazyme dosage: 20 MG; QW; IVDRP. During the same period patient was treated with HYDROXYZINE, DIPYRONE, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5614706-X
Naglazyme side effect was reported by a Health Professional from IRELAND on Jan 16, 2008. Female patient, 13 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia , pulmonary hypertension . Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.


Naglazyme Side Effects Report #5629947-5
Naglazyme side effect was reported by a Health Professional from IRELAND on Jan 28, 2008. Female patient, 13 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cardiac arrest , pneumonia , pulmonary hypertension . Naglazyme dosage: unknown. Patient was hospitalized. Patient died on 01/01/2008.

Naglazyme Side Effects Report #5646419-2
Naglazyme side effect was reported by a Physician from IRELAND on Feb 13, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest , mitral valve incompetence, pneumonia , pulmonary haemorrhage, pulmonary hypertension , respiratory tract infection, tricuspid valve incompetence. Naglazyme dosage: 20 MG QW IV. During the same period patient was treated with MEROPENEM, VANCOMYCIN, ERYTHROMYCIN, CIPROFLOXACIN, VORICONAZOLE, MILRINONE LACTATE, FUROSEMIDE, MORPHINE. Patient was hospitalized. Patient died on 01/25/2008.

Naglazyme Side Effects Report #5679361-1
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 05, 2008. Male patient, child 11 years of age, weighting 55.12 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea at rest, oedema peripheral, pneumonia . Naglazyme dosage: 25 MG; QW; IV. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL, CLAVULANATE POTASSIUM. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6024082-9
Naglazyme side effect was reported by a Physician from BRAZIL on Dec 10, 2008. Male patient, child 10 years of age, weighting 38.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia . Naglazyme dosage: 15 MG; QW; IVDRP. During the same period patient was treated with PARACETAMOL, DEXCHLORPHENIRAMINE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6032162-7
Naglazyme side effect was reported by a Physician from BRAZIL on Dec 10, 2008. Male patient, child 10 years of age, weighting 38.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia . Naglazyme dosage: 15 MG;QW;IVDRP. During the same period patient was treated with ACETAMINOPHEN, DEXCHLORPHENIRAMINE. Patient was hospitalized. Patient recovered.


Naglazyme Side Effects Report #6077131-6
Naglazyme side effect was reported by a Physician from BRAZIL on Jan 27, 2009. Male patient, child 10 years of age, weighting 38.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: asthenia, blood ph decreased, pneumonia . Naglazyme dosage: 15 MG; QW; IVDRP. During the same period patient was treated with ACETAMINOPHEN, DEXCHLORPHENIRAMINE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6096865-0
Naglazyme side effect was reported by a Physician from BRAZIL on Feb 10, 2009. Male patient, child 10 years of age, weighting 38.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: asthenia, eosinophil percentage increased, pneumonia , respiratory tract infection. Naglazyme dosage: 15 MG; QW; IVDRP. During the same period patient was treated with PARACETAMOL, DEXCHLORPHENIRANINE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6015417-1
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Dec 03, 2008. Female patient was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypotension, pneumonia . Naglazyme dosage: unknown. During the same period patient was treated with HYDROXYZINE, DIPYRONE. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6068520-4
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Jan 19, 2009. Female patient, weighting 52.91 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: heart valve replacement, pneumonia . Naglazyme dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6088040-0
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Feb 04, 2009. Female patient, weighting 37.48 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypotension, infusion related reaction, pneumonia . Naglazyme dosage: 20 MG; QW;IV DRP. During the same period patient was treated with HYDROXYZINE, DIPYRONE. Patient was hospitalized. Patient recovered.


Naglazyme Side Effects Report #6090385-5
Naglazyme side effect was reported by a Physician from BRAZIL on Feb 05, 2009. Female patient, weighting 52.91 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: mitral valve incompetence, pneumonia . Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #6123821-6
Naglazyme side effect was reported by a Physician from BRAZIL on Mar 03, 2009. Female patient, weighting 52.91 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: mitral valve incompetence, pneumonia . Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5989166-X
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Nov 19, 2008. Female patient was diagnosed with mucopolysaccharidosis and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypotension, pneumonia . Naglazyme dosage: unknown. During the same period patient was treated with HYDROXYZINE, DIPYRONE. Patient was hospitalized. Patient recovered.